In a rare and urgent joint appeal, Brazilian President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have issued a clarion call to the leaders of the G7, G20, BRICS, and the wider international community. As the world approaches a critical window in multilateral negotiations, the two leaders are demanding that nations bridge their remaining divides to finalize the WHO Pandemic Agreement—a landmark instrument designed to ensure that the catastrophic failures of the COVID-19 era are never repeated.
At the heart of their appeal lies the "Pathogen Access and Benefit-Sharing" (PABS) annex. This technical, yet politically charged, mechanism is the final piece of a complex puzzle that has been under construction for over a year. Without it, the Pandemic Agreement remains a hollow promise, unable to enter into force, leaving the world as vulnerable to the next pathogen as it was in early 2020.
The Memory of Grief: Why the World Must Act
The plea from Geneva and Brasília begins not with diplomatic jargon, but with the raw, collective memory of the recent past. The COVID-19 pandemic did more than disrupt economies; it tore at the social fabric of every nation. Hospitals became war zones; families were forced to say their final goodbyes through glass barriers or smartphone screens; and millions of children faced the permanent absence of grandparents.
Estimates from the WHO and independent researchers place the human toll at up to 20 million lives lost. Beyond the biological devastation, the economic cost was staggering. The International Monetary Fund (IMF) has calculated that the pandemic resulted in over $13 trillion in lost global economic output. This figure manifests in the everyday realities of shuttered small businesses, severed supply chains, and a generation of students whose education was fundamentally compromised.
"Humanity promised itself, in the rawness of that grief, that it would not face such a day again unprepared," the leaders wrote. "We write to you now because that hope is not yet fulfilled."
Chronology: A Path Toward Consensus
The journey toward the current draft of the Pandemic Agreement has been long and fraught with geopolitical tension.
- 2020–2021: The world faces the full brunt of COVID-19, revealing deep-seated inequalities in how vaccines and therapeutics were distributed.
- 2023: Recognizing the systemic failure of the international response, WHO Member States begin formal negotiations on a new Pandemic Agreement.
- May 1, 2024: The most recent negotiating session concludes. While real progress is noted, key issues—specifically regarding equity and the governance of pathogen data—remain unresolved.
- July 6–17, 2024: The pivotal window for the next round of negotiations. President Lula and Dr. Tedros have explicitly urged leaders to treat July 17 as a definitive deadline for concluding the agreement.
The core of the dispute involves the PABS system. This system is intended to create a transparent, predictable framework for the rapid sharing of genetic information about emerging pathogens. In exchange, countries that share this data are guaranteed fair access to the medical countermeasures—such as vaccines and treatments—that are developed from that research.
Supporting Data: The Case for PABS
The argument for the PABS annex is based on both humanitarian necessity and cold, strategic logic.
The Economics of Preparedness
"Solidarity is our best immunity," the authors argue. From a fiscal perspective, investing in a robust global surveillance and distribution system is exponentially cheaper than managing the fallout of a full-scale pandemic. By identifying pathogens at their source, the international community can contain outbreaks before they cross borders, sparing the global economy trillions of dollars and preventing the kind of societal paralysis witnessed during the last decade.
Predictability and Legal Certainty
Currently, the process for accessing and sharing pathogens is improvised, often occurring in the chaotic heat of an unfolding crisis. This leads to delays, hoarding, and inequitable distribution. PABS aims to replace this "case-by-case" improvisation with a single, stable framework. By establishing rules in advance, laboratories and pharmaceutical partners can move with the speed required by modern biology.
The Threat Horizon
The urgency of this task is amplified by shifting environmental and technological landscapes. Scientists estimate a 25% chance of another pandemic within the next ten years. Climate change, evolving agricultural practices, and deforestation are encroaching on wildlife habitats, increasing the likelihood of zoonotic spillover. Furthermore, the rapid advancement of biotechnology, when not matched by equivalent biosafety oversight, introduces the risk of accidental or deliberate release of dangerous pathogens.
Official Responses and Political Hurdles
One of the most persistent concerns raised by skeptical nations is the potential infringement on state sovereignty. Critics have suggested that a WHO-led agreement could empower the organization to dictate domestic policies, such as lockdowns, travel bans, or mandatory vaccination programs.
President Lula and Dr. Tedros have directly addressed these fears, citing Article 22, paragraph 2 of the draft agreement. They clarify that the Agreement and its annexes provide no authority for the WHO to direct or alter a country’s laws or internal policies. Sovereignty remains firmly with the nation-state.
"We ask you, concretely, to instruct your negotiators to come to the July session ready to conclude, and to give them the flexibility to close the remaining gaps," the leaders urged.
Implications: The Legacy of Human Health
The finalization of this Agreement is viewed by its proponents as the "natural next chapter" in the history of human health. The world has successfully eradicated smallpox, brought polio to the brink of extinction, and developed effective interventions for HIV, tuberculosis, and malaria. These successes were not accidents; they were the result of sustained international cooperation.
A Three-Pronged Call to Action
The joint statement concludes with three specific requests for global leaders:
- Political Will at the Highest Level: Negotiators need a clear signal from heads of government that finishing the annex is a national priority. They need the flexibility to move beyond cautious maneuvering toward courageous consensus.
- A Spirit of Equity: Equity must be operational, not just rhetorical. It must be embedded in the "operational detail" of the annex to ensure that the countries sharing dangerous pathogens receive fair, timely access to the life-saving tools derived from that information.
- A Sense of Urgency: July 17 must be viewed as a hard deadline. The next pandemic will not wait for the convenience of diplomatic cycles.
The Cost of Inaction
As the negotiators prepare to reconvene, an Ebola outbreak is currently being managed across two nations. The responders on the ground are working without the benefit of approved vaccines or cures. This is not a hypothetical scenario or a distant, abstract threat—it is a current reality.
"Every month this annex stays unfinished is a month the world is less ready than it could be, and people are less safe than they deserve to be," the statement warns.
The plea from Geneva and Brasília is ultimately a challenge to the conscience of the world’s most powerful leaders. By finalizing the Pandemic Agreement, the current generation has the opportunity to fulfill the promise made in the depths of the COVID-19 crisis: to protect humanity from the next unseen threat through the power of shared, disciplined, and equitable cooperation. As the clock ticks toward July 17, the question remains whether the political class will rise to the challenge, or if they will allow the lessons of the last four years to fade into the history of missed opportunities.
About the Author
